Avigen to Present At Needham and Company Biotechnology Conference
07 juin 2007 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., June 7, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that President and CEO...
Avigen to Present at BIO 2007 International Convention
01 mai 2007 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., May 1, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, announced...
Avigen Announces Pricing of Common Stock Offering
26 avr. 2007 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., April 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) today announced the pricing of an underwritten public offering of 3,974,000 shares of newly issued common stock at a...
Avigen Reports First Quarter 2007 Financial Results
24 avr. 2007 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., April 24, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, today...
Avigen to Present At CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
04 avr. 2007 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., April 4, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions,...
Avigen Receives Approval to Initiate AV650 Phase II Clinical Development
14 mars 2007 08h00 HE
|
Avigen, Inc.
Avigen to Present at Cowen and Company Annual Health Care Conference
Webcast Scheduled for 9:30 a.m. (ET) on Thursday, March 15, 2007
ALAMEDA, Calif., March 14, 2007 (PRIME NEWSWIRE) --...
Avigen to Present at Cowen and Company Annual Health Care Conference
08 mars 2007 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., March 8, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions,...
Avigen to Present At Oppenheimer Pain Management Investor Conference
27 févr. 2007 10h44 HE
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 27, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions,...
Avigen's AV411 Highlighted in Special Issue of Neuron Glia Biology
26 févr. 2007 08h04 HE
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, announced today...
Avigen Reports 2006 Financial Results and Reviews Clinical Progress
07 févr. 2007 08h00 HE
|
Avigen, Inc.
Avigen to Discuss AV411 Safety and Tolerability Trial Results
ALAMEDA, Calif., Feb. 7, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) today reported financial results for fourth...